US Patent Issued to O-FORCE on July 7 for "Amyloid-Beta aggregation inhibitor, pharmaceutical composition foramyloid-Beta aggregation disease, and use application of same" (Japanese Inventors)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,971, issued on July 7, was assigned to O-FORCE Co. LTD (Kochi, Japan).

"Amyloid-Beta aggregation inhibitor, pharmaceutical composition foramyloid-Beta aggregation disease, and use application of same" was invented by Toshifumi Akizawa (Kochi, Japan), Motoaki Saito (Kochi, Japan), Youichirou Higashi (Kochi, Japan) and Rina Nakamura (Kochi, Japan).

According to the abstract* released by the U.S. Patent & Trademark Office: "A drug that inhibits aggregation of amyloid-Beta, which causes Alzheimer's disease and the like. The amyloid-Betaaggregation inhibitor is characterized by containing at least one of a peptide having an amino acid sequence of SEQ ID NO: 1 (GSGNR) or a peptide havin...